Sign in

Antonio Henriques

@antoniohenriques.bsky.social
546 followers 285 following 21 posts

Founder & CEO of Momentum Therapeutics Developing drugs for neurodegeneration and aging Ex-Genentech, Amgen, Sanofi | Boston

PostsRepliesMedia
Reposted by Antonio Henriques
Dan Jagger @auditorynerves.bsky.social · 08/04/2025
"Amid all the warnings about a ‘dementia tsunami’, here are the things you should know. When we dig into new research we see why all the alarming headlines are written, but also that science is bringing new hope." 🧪🧠 #neuroskyence www.theguardian.com/commentisfre...
theguardian.com
Amid all the warnings about a ‘dementia tsunami’, here are the things you should know | Devi Sridhar
When we dig into new research we see why all the alarming headlines are written, but also that science is bringing new hope, says Devi Sridhar, chair of global public health at the University of Edinb...
0145
Antonio Henriques @antoniohenriques.bsky.social · 06/04/2025
God, it's brutal out here
021
Antonio Henriques @antoniohenriques.bsky.social · 26/03/2025
No better way to kick off this next chapter than spending my first full day in Boston—after 8 years in California—at the MassBio conference. Grateful for the warm welcome and excited for what’s ahead.
000
Reposted by Antonio Henriques
Nature Reviews Neurology @natrevneurol.nature.com · 14/03/2025
Interleukin-12 signaling drives Alzheimer’s disease pathology through disrupting neuronal and oligodendrocyte homeostasis www.nature.com/articles/s43...
nature.com
Interleukin-12 signaling drives Alzheimer’s disease pathology through disrupting neuronal and oligodendrocyte homeostasis - Nature Aging
Schneeberger, Kim, Geesdorf, Rajewsky, Heppner et al. tease IL-12 and IL-23 signaling apart in mouse models and human brain tissue to define a role for oligodendroglial and neuronal IL-12 signaling in...
073
Antonio Henriques @antoniohenriques.bsky.social · 05/03/2025
Regardless of how unfair it is that these projects receive funding while therapeutics do not, these mice are ridiculously cute
000
Antonio Henriques @antoniohenriques.bsky.social · 02/03/2025
Watching Severance and interpreting it as a TV show about an intricate clinical trial design makes it even more mind-blowing
120
Antonio Henriques @antoniohenriques.bsky.social · 10/02/2025
Governments should aim to become leaner—when it’s feasible to do more with less. But shedding weight at record speed by cutting off both arms and legs isn’t exactly a winning long-term strategy
000
Antonio Henriques @antoniohenriques.bsky.social · 08/02/2025
Feels like Christmas morning—can’t wait to read this one! @charlespiller.bsky.social
010
Antonio Henriques @antoniohenriques.bsky.social · 06/02/2025
Why limit yourself to developing neurodegenerative therapies when you can also create art? With a cofounder who’s both a scientist and an artist, the possibilities are endless 👨🏻‍🔬👨🏻‍🎨
000
Antonio Henriques @antoniohenriques.bsky.social · 02/02/2025
Excited to share that I'll be attending the Global Healthspan Summit 2025 as Momentum Therapeutics continues advancing our mission to develop novel therapies that protect the nervous system and combat aging. If you'll be there, let’s connect! #Hevolution #Healthspan #GHS2025
000
Reposted by Antonio Henriques
Eric Topol @erictopol.bsky.social · 23/01/2025
We knew about the potential origin of Parkinson's disease from the gut (known as Braak’s hypothesis). But the kidney?! www.nature.com/articles/s41...
nature.com
Propagation of pathologic α-synuclein from kidney to brain may contribute to Parkinson’s disease - Nature Neuroscience
Yuan et al. find that the kidney can serve as a site of initiation for the spread of pathological α-synuclein to the brain, contributing to the development of Parkinson’s disease (PD) and providing a ...
1323946
Antonio Henriques @antoniohenriques.bsky.social · 20/12/2024
This is the mantra. Insitro’s CEO Daphne Koller for Endpoints:
030
Reposted by Antonio Henriques
Eric Topol @erictopol.bsky.social · 17/12/2024
A neurologist with 2 APOE4 copies tells us about his experience with #Alzheimers disease washingtonpost.com/wellness/202...
17375100
Antonio Henriques @antoniohenriques.bsky.social · 12/12/2024
Argentina is the only country in South America with Nobel Prizes in scientific categories, and has made significant contributions to global science, particularly in biochemistry and medicine.
001
Reposted by Antonio Henriques
Shane Liddelow @liddelowsa.bsky.social · 10/12/2024
it's big, and it's a review of 601 papers on the topic - but here's an update on Neuroinflammation in Alzheimer's Disease www.nature.com/articles/s41... led by Michael Heneka, published in @natrevimmunol.bsky.social today (MANY more authors listed and linked below)
nature.com
Neuroinflammation in Alzheimer disease - Nature Reviews Immunology
This Review provides an in-depth examination of how inflammation contributes to neurodegeneration in Alzheimer disease. The authors explore the impact of extrinsic factors, such as brain trauma, diet ...
114451
Antonio Henriques @antoniohenriques.bsky.social · 01/12/2024
Brain delivery has the potential to transform patient care - and it could become a reality soon. This snapshot of transcytosis strategies (from GS) highlights how neurobiotech is on the verge of revolutionizing treatments for CNS diseases. I only wish Montara had been included in the discussion.
000
Antonio Henriques @antoniohenriques.bsky.social · 29/11/2024
A sincere and shameless plug: This Thanksgiving, I’m especially grateful for my healthy axons. Photo Credit: Felipe Court, our Chief Scientific Officer.
030
Reposted by Antonio Henriques
David Sable @dbsable.bsky.social · 24/11/2024
My advice to graduates of my class who still (!) insist on going into #biotech investment banking First, a few tips re science/medical data:
1204
Antonio Henriques @antoniohenriques.bsky.social · 21/11/2024
Neuroscience and obesity continue to stand out as the dominant and perhaps only major headwinds driving biopharma business development this year, consistently delivering impressive deals and partnerships.
020
Reposted by Antonio Henriques
Jason Kelly @jasonrkelly.bsky.social · 20/11/2024
Made a biotech founders starter pack, DM me to be added! go.bsky.app/LWm8uPE
2311639
Antonio Henriques @antoniohenriques.bsky.social · 19/11/2024
Who’s building a neuroscience and a biotech founder “starter packs”? #biosky #medsky
230
Antonio Henriques @antoniohenriques.bsky.social · 15/11/2024
Proud to be part of this movement alongside brilliant peers and friends shaping the future of innovation in biotech.
010
Antonio Henriques @antoniohenriques.bsky.social · 12/11/2024
First post here! Excited to connect, learn, and join meaningful conversations. #BioSky #SciSky
020